Literature DB >> 6895643

The protective effect of sucralfate on the gastric mucosa of rats.

S J Harrington, J F Schlegel, C F Code.   

Abstract

Fasted, anesthetized female rats were used to test the effects of sucralfate (Sc) on the response of the gastric mucosa to ethanol (EtOH) in NaCl or taurocholic acid (TcA) in HCl. The trachea was cannulated and the esophagus and pylorus were ligated. Tubes placed into the stomach permitted instillation of test solutions and determinations of transmucosal potential difference (PD). All periods were 15 min. Each test began with a baseline 150 mM HCl period followed by two treatment periods; in the first, 5600 mg Sc in NaCl or NaCl alone was placed in the stomach; in the second, neutral EtOH or acidified TcA solution was added. In the final two posttreatment test periods, the pH of the gastric contents of the animals treated with Sc was higher, the disappearance of H+ was less, and the index of mucosal damage was reduced. The results demonstrate that Sc has a protective effect on the gastric mucosa of rats. Pretreatment with Sc also reduced the net Cl-loss from the contents and produced an unexplained significant reduction in PD. Sc formed a white coating over the glandular mucosa. This coating may a play a role in its protective action.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895643

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Effect of intragastric pH on mucosal protective action of sucralfate.

Authors:  J Z Danesh; A Duncan; R I Russell; G Mitchell
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

3.  Prevention of duodenal ulcers in the rat using a combination of ranitidine and sucralphate in subtherapeutic doses.

Authors:  S Bank; H Zimmerman; C Smolow; V Kranz
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

Review 4.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

5.  Inability of cytoprotection to occur during a period of gastric ischemia.

Authors:  G M Frydman; A G Penney; C Malcontenti; P E O'Brien
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

6.  Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

7.  Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats.

Authors:  Yarasi Gayathri Ramakrishna; Kumarasamy Savithri; Manfred Kist; Sivasitamparam Niranjali Devaraj
Journal:  BMC Complement Altern Med       Date:  2015-10-19       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.